These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33659292)

  • 1. Direct Reprogramming of Mouse Embryonic Fibroblasts to Conventional Type 1 Dendritic Cells by Enforced Expression of Transcription Factors.
    Rosa FF; Pires CF; Zimmermannova O; Pereira CF
    Bio Protoc; 2020 May; 10(10):e3619. PubMed ID: 33659292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell transcriptional profiling informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells.
    Rosa FF; Pires CF; Kurochkin I; Halitzki E; Zahan T; Arh N; Zimmermannová O; Ferreira AG; Li H; Karlsson S; Scheding S; Pereira CF
    Sci Immunol; 2022 Mar; 7(69):eabg5539. PubMed ID: 35245086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct reprogramming of fibroblasts into antigen-presenting dendritic cells.
    Rosa FF; Pires CF; Kurochkin I; Ferreira AG; Gomes AM; Palma LG; Shaiv K; Solanas L; Azenha C; Papatsenko D; Schulz O; Reis e Sousa C; Pereira CF
    Sci Immunol; 2018 Dec; 3(30):. PubMed ID: 30530727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
    Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
    J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming Cancer Cells to Antigen-presenting Cells.
    Ferreira AG; Zimmermannova O; Kurochkin I; Ascic E; Åkerström F; Pereira CF
    Bio Protoc; 2023 Nov; 13(22):e4881. PubMed ID: 38023788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRF8 and BATF3 interaction enhances the cDC1 specific Pfkfb3 gene expression.
    Chauhan KS; Das A; Jaiswal H; Saha I; Kaushik M; Patel VK; Tailor P
    Cell Immunol; 2022 Jan; 371():104468. PubMed ID: 34968772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103
    Zhou Y; Slone N; Chrisikos TT; Kyrysyuk O; Babcock RL; Medik YB; Li HS; Kleinerman ES; Watowich SS
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32273347
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Theisen DJ; Ferris ST; Briseño CG; Kretzer N; Iwata A; Murphy KM; Murphy TL
    Cancer Immunol Res; 2019 Jan; 7(1):29-39. PubMed ID: 30482745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
    Cancel JC; Crozat K; Dalod M; Mattiuz R
    Front Immunol; 2019; 10():9. PubMed ID: 30809220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoring tumor immunogenicity with dendritic cell reprogramming.
    Zimmermannova O; Ferreira AG; Ascic E; Velasco Santiago M; Kurochkin I; Hansen M; Met Ö; Caiado I; Shapiro IE; Michaux J; Humbert M; Soto-Cabrera D; Benonisson H; Silvério-Alves R; Gomez-Jimenez D; Bernardo C; Bauden M; Andersson R; Höglund M; Miharada K; Nakamura Y; Hugues S; Greiff L; Lindstedt M; Rosa FF; Pires CF; Bassani-Sternberg M; Svane IM; Pereira CF
    Sci Immunol; 2023 Jul; 8(85):eadd4817. PubMed ID: 37418548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding and Modulating Immunity With Cell Reprogramming.
    Pires CF; Rosa FF; Kurochkin I; Pereira CF
    Front Immunol; 2019; 10():2809. PubMed ID: 31921109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity.
    Noubade R; Majri-Morrison S; Tarbell KV
    Front Immunol; 2019; 10():1014. PubMed ID: 31143179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and Characterization of a Functionally Competent Type 2 Conventional Dendritic Cell Line.
    Pigni M; Ashok D; Stevanin M; Acha-Orbea H
    Front Immunol; 2018; 9():1912. PubMed ID: 30197645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy.
    Sánchez-Paulete AR; Teijeira A; Cueto FJ; Garasa S; Pérez-Gracia JL; Sánchez-Arráez A; Sancho D; Melero I
    Ann Oncol; 2017 Dec; 28(suppl_12):xii44-xii55. PubMed ID: 28945841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically applicable CD34
    van Eck van der Sluijs J; van Ens D; Thordardottir S; Vodegel D; Hermens I; van der Waart AB; Falkenburg JHF; Kester MGD; de Rink I; Heemskerk MHM; Borst J; Schaap NPM; Jansen JH; Xiao Y; Dolstra H; Hobo W
    Cancer Immunol Immunother; 2021 Nov; 70(11):3167-3181. PubMed ID: 33796917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRF8 deficiency induces the transcriptional, functional, and epigenetic reprogramming of cDC1 into the cDC2 lineage.
    Lança T; Ungerbäck J; Da Silva C; Joeris T; Ahmadi F; Vandamme J; Svensson-Frej M; Mowat AM; Kotarsky K; Sigvardsson M; Agace WW
    Immunity; 2022 Aug; 55(8):1431-1447.e11. PubMed ID: 35830859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells.
    Carenza C; Calcaterra F; Oriolo F; Di Vito C; Ubezio M; Della Porta MG; Mavilio D; Della Bella S
    Front Immunol; 2019; 10():1325. PubMed ID: 31244860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of Type 1 Porcine Reproductive and Respiratory Syndrome Virus With
    Li Y; Mateu E
    Front Immunol; 2021; 12():674185. PubMed ID: 34177915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 conventional dendritic cell fate and function are controlled by DC-SCRIPT.
    Zhang S; Coughlan HD; Ashayeripanah M; Seizova S; Kueh AJ; Brown DV; Cao W; Jacquelot N; D'Amico A; Lew AM; Zhan Y; Tonkin CJ; Villadangos JA; Smyth GK; Chopin M; Nutt SL
    Sci Immunol; 2021 Apr; 6(58):. PubMed ID: 33811060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.